These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 34608924)

  • 21. High-throughput «Omics» technologies: New tools for the study of triple-negative breast cancer.
    Judes G; Rifaï K; Daures M; Dubois L; Bignon YJ; Penault-Llorca F; Bernard-Gallon D
    Cancer Lett; 2016 Nov; 382(1):77-85. PubMed ID: 26965997
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Min-redundancy and max-relevance multi-view feature selection for predicting ovarian cancer survival using multi-omics data.
    El-Manzalawy Y; Hsieh TY; Shivakumar M; Kim D; Honavar V
    BMC Med Genomics; 2018 Sep; 11(Suppl 3):71. PubMed ID: 30255801
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers.
    Zhang H; Liu L; Zhang J; Chen J; Ye J; Shukla S; Qiao J; Zhan X; Chen H; Wu CJ; Fu YX; Li B
    Clin Cancer Res; 2020 Mar; 26(6):1359-1371. PubMed ID: 31831563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative analysis of protein interactome networks prioritizes candidate genes with cancer signatures.
    Li Y; Sahni N; Yi S
    Oncotarget; 2016 Nov; 7(48):78841-78849. PubMed ID: 27791983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IOBR: Multi-Omics Immuno-Oncology Biological Research to Decode Tumor Microenvironment and Signatures.
    Zeng D; Ye Z; Shen R; Yu G; Wu J; Xiong Y; Zhou R; Qiu W; Huang N; Sun L; Li X; Bin J; Liao Y; Shi M; Liao W
    Front Immunol; 2021; 12():687975. PubMed ID: 34276676
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preface on application of omics technologies in cancer biology and therapy.
    Georgakilas AG
    Cancer Lett; 2016 Nov; 382(1):A1. PubMed ID: 27765153
    [No Abstract]   [Full Text] [Related]  

  • 27. Prognostic and Predictive Biomarkers in Cancer.
    Nair M; Sandhu SS; Sharma AK
    Curr Cancer Drug Targets; 2014; 14(5):477-504. PubMed ID: 24807144
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Data-driven approaches to advance research and clinical care for pediatric cancer.
    Gout AM; Arunachalam S; Finkelstein DB; Zhang J
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188571. PubMed ID: 34051287
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GVES: machine learning model for identification of prognostic genes with a small dataset.
    Ko S; Choi J; Ahn J
    Sci Rep; 2021 Jan; 11(1):439. PubMed ID: 33431999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introduction: Cancer Gene Networks.
    Clarke R
    Methods Mol Biol; 2017; 1513():1-9. PubMed ID: 27807826
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integration of cancer genomics with treatment selection: from the genome to predictive biomarkers.
    Ow TJ; Sandulache VC; Skinner HD; Myers JN
    Cancer; 2013 Nov; 119(22):3914-28. PubMed ID: 24037788
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cancer Subtype Discovery Based on Integrative Model of Multigenomic Data.
    Ge SG; Xia J; Sha W; Zheng CH
    IEEE/ACM Trans Comput Biol Bioinform; 2017; 14(5):1115-1121. PubMed ID: 28113782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Capsule Network Based Modeling of Multi-omics Data for Discovery of Breast Cancer-Related Genes.
    Peng C; Zheng Y; Huang DS
    IEEE/ACM Trans Comput Biol Bioinform; 2020; 17(5):1605-1612. PubMed ID: 30969931
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omics-based identification of biomarkers for nasopharyngeal carcinoma.
    Janvilisri T
    Dis Markers; 2015; 2015():762128. PubMed ID: 25999660
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioinformatics-assisted, integrated omics studies on medicinal plants.
    Ma X; Meng Y; Wang P; Tang Z; Wang H; Xie T
    Brief Bioinform; 2020 Dec; 21(6):1857-1874. PubMed ID: 32706024
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An Efficient Algorithm for the Detection of Outliers in Mislabeled Omics Data.
    Sun H; Wang J; Zhang Z; Hu N; Wang T
    Comput Math Methods Med; 2021; 2021():9436582. PubMed ID: 34976114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Omics-based biomarkers: current status and potential use in the clinic.
    Quezada H; Guzmán-Ortiz AL; Díaz-Sánchez H; Valle-Rios R; Aguirre-Hernández J
    Bol Med Hosp Infant Mex; 2017; 74(3):219-226. PubMed ID: 29382490
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrated analysis of multidimensional omics data on cutaneous melanoma prognosis.
    Jiang Y; Shi X; Zhao Q; Krauthammer M; Rothberg BE; Ma S
    Genomics; 2016 Jun; 107(6):223-30. PubMed ID: 27141884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genomics of pancreatic ductal adenocarcinoma.
    Pilarsky C; Grutzmann R
    Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):381-5. PubMed ID: 25100122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative study of multi-omics integration tools for cancer driver gene identification and tumour subtyping.
    Sathyanarayanan A; Gupta R; Thompson EW; Nyholt DR; Bauer DC; Nagaraj SH
    Brief Bioinform; 2020 Dec; 21(6):1920-1936. PubMed ID: 31774481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.